|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-6-20
|
|
pubmed:abstractText |
Seven children with newly diagnosed acquired severe aplastic anemia (SAA) were treated with a combination of long-term granulocyte-macrophage colony-stimulating factor (GM-CSF) and immunosuppression to assess the potential for GM-CSF to induce sustained neutrophil recovery, reduce the incidence of infection, and enhance the therapeutic efficacy of immunosuppression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1077-4114
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
140-4
|
|
pubmed:dateRevised |
2011-10-6
|
|
pubmed:meshHeading |
pubmed-meshheading:7749763-Adolescent,
pubmed-meshheading:7749763-Anemia, Aplastic,
pubmed-meshheading:7749763-Antilymphocyte Serum,
pubmed-meshheading:7749763-Child,
pubmed-meshheading:7749763-Child, Preschool,
pubmed-meshheading:7749763-Cyclosporine,
pubmed-meshheading:7749763-Drug Administration Schedule,
pubmed-meshheading:7749763-Drug Therapy, Combination,
pubmed-meshheading:7749763-Female,
pubmed-meshheading:7749763-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:7749763-Humans,
pubmed-meshheading:7749763-Immunosuppressive Agents,
pubmed-meshheading:7749763-Infant,
pubmed-meshheading:7749763-Male,
pubmed-meshheading:7749763-Prednisone
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia.
|
|
pubmed:affiliation |
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2588, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
